FDA-无菌药品生产指南(中英文版)介绍
VIP免费
Copyright SCI Version 1
Translated from / 译自:
Guidance for Industry
Sterile Drug Products
Produced by Aseptic Processing —
Current Good Manufacturing Practice
行业指南
无菌加工生产的无菌药品
—现行的生产质量管理规范(cGMP)
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Office of Regulatory Affairs (ORA)
September 2004
Pharmaceutical CGMPs
Copyright SCI Version 1
Guidance for Industry
Sterile Drug Products
Produced by Aseptic Processing —
Current Good Manufacturing Practice
Additional copies are available from:
Office of Training and Communication
Division of Drug Information, HFD-240
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857
(Tel) 301-827-4573
http://www.fda.gov/cder/guidance/index.htm
or
Office of Communication, Training and
Manufacturers Assistance, HFM-40
Center for Biologics Evaluation and Research
Food and Drug Administration
1401 Rockville Pike, Rockville, MD 20852-1448
http://www.fda.gov/cber/guidelines.htm.
(Tel) Voice Information System at 800-835-4709 or 301-827-1800
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Office of Regulatory affairs (ORA)
September 2004
Pharmaceutical CGMPs
Contains Nonbinding Recommendations
Copyright SCI Version 1
TABLE OF CONTENTS
I. INTRODUCTION............................................................................................................. 1
简介
II. BACKGROUND ............................................................................................................... 2
背景
A. Regulatory Framework ................................................................................................................. 2
法规架构
B. Technical Framework .................................................................................................................... 3
技术架构
III. SCOPE ............................................................................................................................... 4
适用范围
IV. BUILDINGS AND FACILITIES .................................................................................... 6
厂房和建筑
A. Critical Area – Class 100 (ISO 5) ................................................................................................. 8
关键区域– 100 级 (ISO 5)
B. Supporting Clean Areas .............................................................................................................. 11
辅助洁净区域
C. Clean Area Separation ................................................................................................................ 11
净化区的隔离
D. Air Filtration ................................................................................................................................ 12
空气过滤
1. Membrane ...................................................................................................................................... 13
膜过滤
2. High-Efficiency Particulate Air (HEPA) ....................................................................................... 14
高效颗粒空气过滤器
(HEPA)
E. Design ............................................................................................................................................ 16
设计
V. PERSONNEL TRAINING, QUALIFICATION, & MONITORING ........................ 20
人员的培训,资格认定和监控
A. Personnel ....................................................................................................................................... 21
人员
B. Laboratory Personnel .................................................................................................................. 25
实验室人员
C. Monitoring Program .................................................................................................................... 25
监控程序
VI. COMPONENTS AND CONTAINER/CLOSURES .................................................... 27
药品成分和容器/密封
A. Components .................................................................................................................................. 27
摘要:
展开>>
收起<<
CopyrightSCIVersion1Translatedfrom/译自:GuidanceforIndustrySterileDrugProductsProducedbyAsepticProcessing—CurrentGoodManufacturingPractice行业指南无菌加工生产的无菌药品—现行的生产质量管理规范(cGMP)U.S.DepartmentofHealthandHumanServicesFoodandDrugAdministrationCenterforDrugEvaluationandResearch(CDER)CenterforBiologicsEvaluation...
声明:如果您的权利被侵害,请联系我们的进行举报。
相关推荐
-
医疗器械设计开发控制指南VIP免费
2024-04-12 402 -
YY∕T 0664-2020医疗器械软件软件生存周期过程核查表VIP免费
2024-04-12 445 -
创新医疗器械注册申报流程
2024-05-02 209 -
20221028_医疗器械生产现场核查缺陷分析交流(江苏药省监局审核查验中心) (1)VIP免费
2024-05-09 162 -
医疗器械网络安全漏洞自评报告VIP专享
2024-11-18 386 -
内审检查表 MDR法规VIP免费
2025-04-07 405 -
核查中心2025年第一批医疗器械飞行检查情况汇总.pdfVIP免费
2025-05-27 183 -
特定上市前提交审查的质量管理体系信息-2025草案_中英文版VIP专享
2025-11-03 130 -
医疗器械生产企业质量管理体系程序文件模板全套VIP免费
2026-05-11 71 -
医疗器械质量管理体系-质量手册-2026(国家局2025第107号)VIP专享
2026-06-04 214
作者:冒牌货
分类:专业资料
价格:60质量币
属性:102 页
大小:874.82KB
格式:PDF
时间:2026-01-07

